We are dedicated to finding a cure for all types of breast cancer. We do this by researching mutated and altered genes that are responsible for the development and progression of breast cancer, as well as genes that lead to drug resistance. We are also actively involved with the Vanderbilt Breast Cancer Research Program's clinical research team to translate our work into clinical practice and patient care.

More about Dr. Park:
Dr. Park received his undergraduate degree with honors from the University of Chicago in 1989.  He then completed a dual M.D., Ph.D. training program at the University of Pennsylvania School of Medicine in 1995. Dr. Park completed a residency in Internal Medicine and Hematology/Oncology Fellowship training at the Hospital of the University of Pennsylvania. In 2001, Dr. Park finished a postdoctoral research fellowship in cancer genetics in the laboratory of Dr. Bert Vogelstein at Johns Hopkins.  In 2002, Dr. Park joined the faculty in the Department of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. In 2018, Dr. Park moved to Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center where he is the Benjamin F. Byrd, Jr. Chair in Oncology, Professor of Medicine, Division of Hematology/Oncology, and Director, the Vanderbilt-Ingram Cancer Center.

Graduate program affiliations:
Cellular & Molecular Medicine
Human Genetics
Pathobiology
Chemical and Biomolecular Engineering

Cancer Biology (VUMC) ​